Walt Woltosz, chairman and CEO of Simulations Plus, said: “DDDPlus remains the only program of its kind in the world today. DDDPlus saves time and money.
Rather than an iterative process of design-experiment-design-experiment, DDDPlus enables formulation scientists to run a single experiment to calibrate the model for a particular type of dosage form, and then to use simulations to investigate which changes in the formulation or in the experiment will achieve the desired results.”